Endologix Announces Temporary Hold on AFX to Resolve a Manufacturing Issue - Endologix

Skip to content

PAD
AAA
IFU’s
About Us

PAD
AAA
IFU’s
About Us

Search

December 27, 2016

Endologix Announces Temporary Hold on AFX to Resolve a Manufacturing Issue

PrevPreviousEndologix Receives Australian Therapeutic Goods Administration (TGA) Approval for AFX®2 Bifurcated Endograft System

NextEndologix Resumes Shipments and Procedures with AFX® and Some Sizes of AFX®2 Schedules Conference Call for December 30, 2016 at 9:00 am ETNext

Youtube Linkedin Twitter

Safety Information

Anti-Trafficking/Modern Slavery

Terms & Conditions

© 2026 Endologix LLC. All rights reserved.

Endologix^® products and associated components are not available in all countries or regions. Please contact your Endologix representative for details regarding product availability. Prior to use, refer to the “Instructions for Use” for complete and specificindications, contraindications, all warnings and precautions. Rx only.